| Net sales growth (both segments, YoY) | +3% | CFO |
| Gross profit growth (YoY) | +1% | CFO |
| Specialty Technology Solutions net sales growth (YoY) | +3% | CFO |
| Specialty Technology Solutions net sales growth (QoQ) | +4% | CFO |
| Specialty Technology Solutions adjusted EBITDA margin | 2.8% | CFO |
| Intelisys & Advisory net sales growth (YoY) | +3% | CFO |
| Intelisys & Advisory annual net billings | ~$2.85 billion | CFO |
| Intelisys & Advisory adjusted EBITDA margin | 41% | CFO |
| Cash at quarter end | ~$83 million | CFO |
| Net debt leverage ratio (trailing 12-month adjusted EBITDA) | ~0x | CFO |
| Adjusted ROIC (Q2) | 11.9% | CFO |
| Adjusted ROIC (trailing 12 months) | 13.3% | CFO |
| Share repurchases (Q2) | $18 million | CFO |
| Remaining share repurchase authorization | $179 million | CFO |
| Full-year revenue guidance | $3.0–$3.1 billion | CFO |
| Full-year adjusted EBITDA guidance | $140–$150 million | CFO |
| Full-year free cash flow guidance | at least $80 million | CFO |